Flow cytometry demonstrated a marked reduction in tumor-infiltrating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells, indicating modulation of the tumor immune microenvironment. Here, FOXP3 is linked to neoplasm.